glp-1 news 2025 november 25 weight loss drug Weight-Loss Drugs Could Address a Range of Addictions GLP-1 Trends: Access & Shortages, – 2025 ADA Highlights: A New

Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11

And while a second round is sometimes needed, many people experience long-term clarity after just one course

Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy

doi: 10.1111/cns.12758 99 OkadaTMutoEYamanakaTUchinoHInazuM

All mice recovered for 2 weeks post surgery before the start of dosing, and mice that did not recover within 3% of their pre-surgery body weight were removed from the study

Demonstrates antioxidant and anti-inflammatory signaling effects in preclinical research